Sodium 4-Butyl-3,5-Dioxo-1,2-Diphenylpyrazolidin-4-Ide 4-丁基-1,2-二苯基-3,5-吡唑烷二酮钠盐

CAS 129-18-0 MFCD01749404

化学结构图

129-18-0
SMILES: CCCCc1c([O-])n(-c2ccccc2)n(-c2ccccc2)c1=O.[Na+]

化学属性

Mol. FormulaC19H19N2NaO2
Mol. Weight330.36

别名和识别编码

Chemical NameSodium 4-Butyl-3,5-Dioxo-1,2-Diphenylpyrazolidin-4-Ide
EC Number204-935-7
Synonym Sodium 4-butyl-3,5-dioxo-1,2-diphenylpyrazolidin-4-ide {LY} Sodium 4-butyl-3,5-dioxo-1,2-diphenylpyrazolidin-4-ide {} {LY} Sodium 4-butyl-3,5-dioxo-1,2-diphenylpyrazolidin-4-ide {} {} {LY} Sodium 4-butyl-3,5-dioxo-1,2-diphenylpyrazolidin-4-ide {} {} {} {LY} Sodium 4-butyl-3,5-dioxo-1,2-diphenylpyrazolidin-4-ide {} {} {} {} {LY} Sodium 4-butyl-3,5-dioxo-1,2-diphenylpyrazolidin-4-ide {} {} {} {} {} {LY} Sodium 4-butyl-3,5-dioxo-1,2-diphenylpyrazolidin-4-ide {} {} {} {} {} {} {LY} Sodium 4-butyl-3,5-dioxo-1,2-diphenylpyrazolidin-4-ide {} {} {} {} {} {} {} {LY} Sodium 4-butyl-3,5-dioxo-1,2-diphenylpyrazolidin-4-ide {} {} {} {} {} {} {} {} { {} {} {} {} {} {} {} {} {LY} Sodium 4-butyl-3,5-dioxo-1,2-diphenylpyrazolidin-4-ide {} {} {} {} {} {} {} {} {} {LY} Sodium 4-butyl-3,5-dioxo-1,2-diphenylpyrazolidin-4-ide {} {} {} {} {} {} {} {} {} {} {LY} Sodium 4-butyl-3,5-dioxo-1,2-diphenylpyrazolidin-4-ide {} {} {} {} {} {} {} {} {} {} {} {LY} Sodium 4-butyl-3,5-dioxo-1,2-dipheny
CAS Number129-18-0
MDL NumberMFCD01749404
Chemical Name Translation4-丁基-1,2-二苯基-3,5-吡唑烷二酮钠盐
Wiswesser Line NotationT5VNNV EHJ BR& CR& E4 &-NA-
LabNetwork Molecule IDLN04603305
PubChem Substance ID46174103
InChIInChI=1S/C19H19N2O2.Na/c1-2-3-14-17-18(22)20(15-10-6-4-7-11-15)21(19(17)23)16-12-8-5-9-13-16;/h4-13H,2-3,14H2,1H3;/q-1;+1
Canonical SMILESO=C([C-](C1=O)CCCC)N(N1C2=CC=CC=C2)C3=CC=CC=C3.[Na+]
信息真实价格透明    资金保障    专业采购外包团队在线服务   
信息真实价格透明    资金保障    专业采购外包团队在线服务   
品牌质保精细包装    现货库存    一流品牌服务   

安全信息

RTECSUQ8300000 
TYPE OF TEST            : LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE       : Intraperitoneal
SPECIES OBSERVED        : Rodent - mouse
DOSE/DURATION           : 169 mg/kg
TOXIC EFFECTS :
   Details of toxic effects not reported other than lethal dose value
REFERENCE :
   RPOBAR Research Progress in Organic-Biological and Medicinal Chemistry. (New
   York, NY)  V.1-3, 1964-72.  Discontinued.  Volume(issue)/page/year:
   2,314,1970

TYPE OF TEST            : LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE       : Intravenous
SPECIES OBSERVED        : Rodent - rabbit
DOSE/DURATION           : 146 mg/kg
TOXIC EFFECTS :
   Details of toxic effects not reported other than lethal dose value
REFERENCE :
   SMWOAS Schweizerische Medizinische Wochenschrift.  (Schwabe & Co.,
   Steintorst 13, 4010 Basel, Switzerland)  V.50-    1920-
   Volume(issue)/page/year: 84,1315,1954

TYPE OF TEST            : LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE       : Subcutaneous
SPECIES OBSERVED        : Rodent - rat
DOSE/DURATION           : 310 mg/kg
TOXIC EFFECTS :
   Behavioral - somnolence (general depressed activity)
REFERENCE :
   ARZNAD Arzneimittel-Forschung. Drug Research.  (Editio Cantor Verlag,
   Postfach 1255, W-7960 Aulendorf, Fed. Rep. Ger.)  V.1-    1951-
   Volume(

TYPE OF TEST            : LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE       : Intravenous
SPECIES OBSERVED        : Rodent - mouse
DOSE/DURATION           : 94 mg/kg
TOXIC EFFECTS :
   Details of toxic effects not reported other than lethal dose value
REFERENCE :
   FRPSAX Farmaco, Edizione Scientifica. (Casella Postale 227, 27100 Pavia,
   Italy)  V.8-43 1953-88 For publisher information, see FRMCE8
   Volume(issue)/page/year: 13,922,1958

TYPE OF TEST            : LDLo - Lowest published lethal dose
ROUTE OF EXPOSURE       : Oral
SPECIES OBSERVED        : Human - woman
DOSE

TYPE OF TEST            : Mutation test systems - not otherwise specified
TEST SYSTEM             : Human Lymphocyte
DOSE/DURATION           : 2160 umol/L
REFERENCE :
   HUMAA7 Humangenetik.  (Heidelberg, Fed. Rep. Ger.)  V.1-30, 1964-75.  For
   publisher information, see HUGEDQ.  Volume(issue)/page/year: 12,330,1971

Storage condition

其他信息

  • MOL 文件:129-18-0.mol
  • 急性毒性:口服-小鼠 LD50: 476 毫克/公斤; 腹腔-大鼠 LD50: 169 毫克/公斤
  • 类别:有毒物质
  • 毒性分级:高毒
  • 储运特性:库房通风低温干燥; 与食品原料类分开存放
  • 灭火剂:水,干粉、干砂、二氧化碳、泡沫、1211灭火剂
  • 下游产品:保泰松
  • 用途一:解热镇痛药，用于治疗风湿性和类风湿性关节炎及痛风等
  • 可燃性危险特性:热分解排出有毒氮氧化物和氧化钠烟雾

系列性分类

相关产品推荐